Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Home
Member Profile
Madhusudan Grover
Personal Information
Title
Associate Professor
Expertise
Gastro-Intestinal (GI)
Institution
Mayo Clinic Rochester
Newsletter?
Not signed up.
Data Summary
Type
Count
Grants/SubContracts
1
Progress Reports
1
Publications
0
Protocols
0
Committees
2
Grants/Applications
Progress Reports
Publications
Presentations
Protocols
Committees
Dynamic Positron Emission Tomography Imaging with 11C-ER176 to Delineate Macrophage Activation in Diabetic Gastroparesis
Diabetic gastroparesis (DG) is a serious complication of diabetes mellitus which results in significant morbidity. Patients suffer from chronic symptoms of nausea, fullness, bloating and abdominal pain. These often result in malnutrition as well as interfere with appropriate management of their diabetes mellitus. Recent advancements driven by work in hyperglycemic animal models as well as full thickness gastric biopsies from patients with DG have demonstrated a macrophage-driven immune dysregulation as central to its pathogenesis. Activated tissue macrophages, likely through paracrine mediators, induce injury to the interstitial cells of Cajal, the gastric pacemaker cells which are also involved in mechanotransduction. An enrichment of markers associated with pro-inflammatory macrophages as well as loss of anti-inflammatory macrophages has been demonstrated in gastroparesis. There are currently no non-invasive ways of assessing immunopathology in the gastric muscle. Additionally, cellular changes can be patchy and untargeted full-thickness biopsies do not allow a comprehensive assessment of the gastric wall. Recently, there have been advancements in radioligands that can be used to delineate activated macrophages. A novel, third-generation translocator protein (TSPO)-specific radioligand is 11C-ER176, which has shown high affinity and excellent in vivo target-to-background binding. Our preliminary data shows that TSPO is expressed in human gastric muscle macrophages. The overall goal of this proposal is to determine the feasibility of 11C-ER176 dynamic PET/CT imaging for detecting macrophage activation in vivo in gastric muscle of patients with DG. In this pilot and feasibility study, we will examine a group of DG patients and matched healthy volunteers with this imaging. Additionally, imaging findings will be validated using tissue assessment of patients using cytometry by time of flight (CyTOF). We anticipate that patients with DG will have enrichment of activated macrophages, which will be detected by an uptake of 11C-ER176 on dynamic PET imaging. This will be associated with enrichment of pro-inflammatory cellular markers on assessment of gastric muscle tissue. Together, this study opens a new paradigm for in vivo assessment of neuromuscular immunopathology in DG, which typically requires invasive, deep tissue biopsy. A successful application of this technique will open avenues for noninvasive assessment and guiding treatment trials for diabetic gastroenteropathy as well as other inflammatory gut disorders.
Progress Reports
Drag a column header and drop it here to group by that column
Application
Complete Date
Report
Options
Dynamic Positron Emission Tomography Imaging with 11C-ER176 to Delineate Macrophage Activation in Diabetic Gastroparesis (Grover, Madhusudan)
6/23/2023
View Progress Report Document
Annual Reports
No uploaded documents found.
Publication
Altmetrics
Submitted By
PubMed ID
Status
Options
No records to display.
No uploaded documents found.
No protocols found.
Name
Description
Steering Committee
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
Gastro-Intestinal (GI)
The DiaComp Gastro-Intestinal (GI) Committee has the principal function of furthering the mission of the consortium with regard to diabetic gastro-intestinal (GI) and liver disease
Curation Flag Information
Display Stats
New comment to be added:
Flag Active?
OrderID
Experiment
Species
Status
Measurements
Options
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!